Menu

Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

The role of soluble CD163, a biomarker of adipose tissue macrophage activation, in the etiology of type 2 diabetes mellitus

CRC-seminars
Zhila Semnani-Azad is currently a doctoral candidate under the supervision of Dr. Anthony Hanley at the University of Toronto. Her research interests include the metabolic and nutritional epidemiology of type 2 diabetes mellitus (T2DM). Zhila’s primary research focuses on understanding the role of chronic subclinical inflammation in the development of T2DM and its related disorders through a novel biomarker of adipose tissue macrophage activation, namely soluble CD163. Her work uses data from the Prospective Metabolism and Islet Cell Evaluation (PROMISE) cohort, an ongoing longitudinal observational study of subjects at high-risk for T2DM. In addition, Zhila is also investigating the role of insulin clearance in the pathophysiology of T2DM. Department of Nutritional Sciences Facult of Medicine, University of Toronto

Host: Paul Franks

Time: 
19 April 2018 13:00 to 14:00
Location: 
Seminar room 60-12-015, CRC

About the event

Time: 
19 April 2018 13:00 to 14:00
Location: 
Seminar room 60-12-015, CRC

Lund University Diabetes Centre, CRC, SUS Malmö, Jan Waldenströms gata 35, House 91:12. SE-214 28 Malmö. Telephone: +46 40 39 10 00